Considering 30-days investment horizon, AstraZeneca PLC is expected to under-perform the SanofiAventis. In addition to that, AstraZeneca is 1.05 times more volatile than SanofiAventis. It trades about -0.33 of its total potential returns per unit of risk. SanofiAventis is currently generating about -0.3 per unit of volatility. If you would invest 3,774 in SanofiAventis on April 25, 2012 and sell it today you would lose (351.00) from holding SanofiAventis or give up 9.3% of portfolio value over 30 days.
Diversification
Average diversification
Overlapping area represents amount of risk that can be diversified away by holding AstraZeneca PLC and SanofiAventis in the same portfolio (assuming nothing else is changed)
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
